Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The risk of bias was assessed using the Cochrane Risk of Bias 2 tool
In addition to monitoring for progressive DR with the assistive technologies discussed, prophylactic treatment with anti-VEGF injections should be considered to reduce DR progression
This is a supplement product advertisement
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
PloS one, 18 (8), e0288911.
US$ 26.23
US$ 26.26
US$ 20.52
US$ 21.56
US$ 22.36
US$ 21.41
US$ 27.27
